CtBP1 activators are chemical entities that stimulate the activity or augment the expression of the CtBP1 protein, known in full as C-terminal binding protein 1. CtBP1 is a unique protein with multifaceted roles within the cell, primarily recognized for its functions as a transcriptional corepressor. It associates with numerous transcription factors and other corepressors, thereby modulating the expression of a vast array of target genes. The protein plays an influential role in various cellular processes, including cell cycle progression, differentiation, and apoptosis, by regulating the transcription of specific genes.
At the molecular level, CtBP1 operates by binding to a specific motif found in many transcription factors. Once bound, CtBP1 can recruit additional proteins, including other corepressors and histone deacetylases, to modify chromatin structure and suppress gene transcription. The activity of CtBP1 is also intriguingly linked to its metabolic state. It possesses a dehydrogenase domain, allowing it to bind to NADH. The NADH-bound form of CtBP1 has a higher affinity for its transcriptional partners, indicating a link between cellular metabolism and transcriptional repression by CtBP1. Activators of CtBP1 can amplify its corepressor activities, leading to alterations in the transcriptional landscape of the cell. By understanding the nuances of CtBP1 activation and the consequent impacts on gene expression, we gain insights into the intricate interplay of metabolism, transcriptional regulation, and cellular outcomes. The modulation of CtBP1 activity by activators underscores the complex layers of cellular regulation that intertwine to maintain cellular health and respond to changing environmental conditions. The study of CtBP1 activators offers a lens through which we can explore the profound ways cells manage gene expression to ensure proper function and adaptation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D interferes with DNA transcription. It might influence CTBP1 expression indirectly by its broad effects on transcriptional processes. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A is a DNA-binding agent that can modify transcription. It could potentially influence CTBP1 expression through its transcriptional effects. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate inhibits dihydrofolate reductase, affecting DNA synthesis. Its broad effects on DNA synthesis might indirectly influence CTBP1 expression. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin forms DNA adducts leading to DNA damage. The cellular response to DNA damage might include changes in CTBP1 expression. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Taxol stabilizes microtubules and interferes with mitotic spindle formation. This could lead to indirect effects on CTBP1 expression through cell cycle disruption. | ||||||
Aminopterin | 54-62-6 | sc-202461 | 50 mg | $102.00 | 1 | |
Aminopterin is an antineoplastic agent that inhibits dihydrofolate reductase. Like methotrexate, its effects on DNA synthesis could indirectly influence CTBP1 expression. | ||||||
Coenzyme Q10 | 303-98-0 | sc-205262 sc-205262A | 1 g 5 g | $71.00 $184.00 | 1 | |
Coenzyme Q10 is involved in electron transport in mitochondria. Changes in cellular energetics might indirectly influence CTBP1 expression. | ||||||
13-cis-Retinoic acid | 4759-48-2 | sc-205568 sc-205568A | 100 mg 250 mg | $75.00 $120.00 | 8 | |
13-cis-Retinoic acid affects cell proliferation and differentiation. These broad cellular effects might have downstream consequences on CTBP1 expression. | ||||||
4-Hydroxyphenylretinamide | 65646-68-6 | sc-200900 sc-200900A | 5 mg 25 mg | $104.00 $315.00 | ||
Fenretinide induces apoptosis in various cell types. The cellular response to apoptosis induction might include changes in CTBP1 expression. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
β-Estradiol binds to estrogen receptors and modulates gene expression. It might have indirect effects on CTBP1 expression through estrogen-responsive genes. | ||||||